#VELA investee #CDT Conduit Pharmaceuticals – Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub March 13, 2024 – Posted in: Vela Technologies Plc (VELA)
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit”) today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation. This strategic acquisition marks a pivotal milestone for Conduit, positioning the Company for portfolio expansion, enhanced development capabilities, and growth of a robust intellectual property portfolio. The laboratory…
Continue reading